Lenskart Solutions Ltd
NSE: LENSKART BSE: 544600Retail
Incorporated in 2008,Lenskart Solutions is a technology-focused eyewear company involved in the design, manufacturing, branding, and retail of prescription eyeglasses, sunglasses, contact lenses, and accessories.[1]
₹475
52W: ₹356 — ₹560
PE 390 · Book ₹38.8 · +1124% vs bookMarket Cap₹82,454 Cr
Stock P/E390Price to Earnings
ROCE3.91%Return on Capital
ROE2.19%Return on Equity
Div. Yield0%Face Value ₹2
Strengths
- +Debtor days have improved from 28.0 to 19.0 days.
- +Company's working capital requirements have reduced from 96.5 days to 62.6 days
Weaknesses
- −Stock is trading at 12.0 times its book value
- −Though the company is reporting repeated profits, it is not paying out dividend
- −Promoter holding is low: 17.6%
- −Company has a low return on equity of 2.53% over last 3 years.
- −Earnings include an other income of Rs.185 Cr.
Shareholding Pattern
Promoters17.55%
FIIs4.26%
DIIs15.48%
Public62.3%
| Category | Dec 2025 | Mar 2026 |
|---|---|---|
| Promoters | 17.57% | 17.55%▼0.0 |
| FIIs | 3.86% | 4.26%▲0.4 |
| DIIs | 15.86% | 15.48%▼0.4 |
| Public | 62.3% | 62.3% |
Financial Statements
| Metric | Sep 2024 | Dec 2024 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Sales | 1,081 | 1,006 | 1,168 | 1,229 | 1,381 |
| Expenses | 919 | 902 | 967 | 1,006 | 1,129 |
| Operating Profit | 162 | 104 | 201 | 223 | 252 |
| OPM % | 15% | 10% | 17% | 18% | 18% |
| Net Profit | 107 | 37 | 104 | 99 | 109 |
| EPS ₹ | 13.85 | 0.48 | 1.35 | 1.2 | 0.63 |
AI Insights
Revenue Trend
Mar 2025 revenue at ₹4,039Cr, up 26.7% YoY. OPM at 11%.
Debt Position
Borrowings at ₹1,549Cr. Debt-to-equity ratio: 0.24x. Healthy balance sheet.
Capex Cycle
CWIP at ₹62Cr (3% of fixed assets). Moderate ongoing capital expenditure.
Margin & Efficiency
ROCE improving from 0% (Mar 2021) to 4% (Mar 2025). Working capital days: 63.
Valuation
PE 390x with 3.91% ROCE. Price is 1124% above book value of ₹38.8. Dividend yield: 0%.
Recent Announcements
- Monitoring Agency Report For The Quarter Ended March 31 2026 14 May - CARE monitoring report for Q4 FY2026 shows IPO proceeds used as planned; no deviations noted.
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 12 May
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 11 May - Alpha Wave sold 43 million Lenskart shares; holding fell to 4.67% on May 8, 2026.
- Announcement Under Regulation 30 (LODR)- Grant Of Stock Options Under Lenskart Employee Stock Option Plan 2021 9 May - Lenskart granted 3,47,000 ESOPs on May 8, 2026 at ₹389 per share.
- Board Meeting Intimation for Intimation Of Board Meeting 30 Apr - Board meeting on May 20, 2026 to approve audited FY26 standalone and consolidated results.
- Financial Year 2025 from web
- Financial Year 2024 from web
- Financial Year 2023 from web